Dimitrakopoulou-Strauss A - Search Results

1

Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe).

Hassel JC, Jiang H, Bender C, Winkler J, Sevko A, Shevchenko I, Halama N, Dimitrakopoulou-Strauss A, Haefeli WE, Jäger D, Enk A, Utikal J, Umansky V. Hassel JC, et al. Oncoimmunology. 2017 May 16;6(9):e1326440. doi: 10.1080/2162402X.2017.1326440. eCollection 2017. Oncoimmunology. 2017. PMID: 28932631 Free PMC article.

2

Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study.

Sachpekidis C, Larribere L, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A, Hassel JC. Sachpekidis C, et al. Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):386-96. doi: 10.1007/s00259-014-2944-y. Epub 2014 Oct 31. Eur J Nucl Med Mol Imaging. 2015. PMID: 25359635

3

18F-FDG PET/CT Reveals Disease Remission in a Patient With Ipilimumab-Refractory Advanced Melanoma Treated With Pembrolizumab.

Sachpekidis C, Hassel JC, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Clin Nucl Med. 2016 Feb;41(2):156-8. doi: 10.1097/RLU.0000000000001039. Clin Nucl Med. 2016. PMID: 26545022

4

Safety of the PD-1 antibody pembrolizumab in patients with high-grade adverse events under ipilimumab treatment.

Bender C, Dimitrakopoulou-Strauss A, Enk A, Hassel JC. Bender C, et al. Ann Oncol. 2016 Jul;27(7):1353-4. doi: 10.1093/annonc/mdw128. Epub 2016 Mar 6. Ann Oncol. 2016. PMID: 26951629 Free article. No abstract available.

5

Vemurafenib and ipilimumab: A promising combination? Results of a case series.

Hassel JC, Lee SB, Meiss F, Meier F, Dimitrakopoulou-Strauss A, Jäger D, Enk AH. Hassel JC, et al. Oncoimmunology. 2015 Oct 29;5(4):e1101207. doi: 10.1080/2162402X.2015.1101207. eCollection 2016 Apr. Oncoimmunology. 2015. PMID: 27141385 Free PMC article.

6

Fractal and multifractal analysis of PET/CT images of metastatic melanoma before and after treatment with ipilimumab.

Breki CM, Dimitrakopoulou-Strauss A, Hassel J, Theoharis T, Sachpekidis C, Pan L, Provata A. Breki CM, et al. EJNMMI Res. 2016 Dec;6(1):61. doi: 10.1186/s13550-016-0216-5. Epub 2016 Jul 29. EJNMMI Res. 2016. PMID: 27473846 Free PMC article.

7

Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.

Dick J, Lang N, Slynko A, Kopp-Schneider A, Schulz C, Dimitrakopoulou-Strauss A, Enk AH, Hassel JC. Dick J, et al. Immunotherapy. 2016 Sep;8(9):1033-44. doi: 10.2217/imt-2016-0083. Immunotherapy. 2016. PMID: 27485076

8

Ipilimumab has efficacy in metastatic Merkel cell carcinoma: a case series of five patients.

Winkler JK, Dimitrakopoulou-Strauss A, Sachpekidis C, Enk A, Hassel JC. Winkler JK, et al. J Eur Acad Dermatol Venereol. 2017 Sep;31(9):e389-e391. doi: 10.1111/jdv.14193. Epub 2017 Mar 22. J Eur Acad Dermatol Venereol. 2017. PMID: 28256019 No abstract available.

9

Severe Ocular Myositis After Ipilimumab Treatment for Melanoma: A Report of 2 Cases.

Pushkarevskaya A, Neuberger U, Dimitrakopoulou-Strauss A, Enk A, Hassel JC. Pushkarevskaya A, et al. J Immunother. 2017 Sep;40(7):282-285. doi: 10.1097/CJI.0000000000000178. J Immunother. 2017. PMID: 28604554

10

[Malignant melanoma : Current status].

Winkler JK, Buder-Bakhaya K, Dimitrakopoulou-Strauss A, Enk A, Hassel JC. Winkler JK, et al. Radiologe. 2017 Oct;57(10):814-821. doi: 10.1007/s00117-017-0281-4. Radiologe. 2017. PMID: 28730266 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters